Other Clinical Trial - Diabetes Education With Real-time Continuous

Status Recruiting

Clinical Trial Summary

Determine the impact of the Compañeros en Salud (Partners in Health) curriculum in conjunction with RT-CGM on glycemic control in Latinx patients with T2D. Participants will be randomized to receive the Companeros en Salud diabetes self-management education and support (DSMES) intervention with or without RT-CGM

Clinical Trial Description

The prevalence of type 2 diabetes is increasing especially in the Latinx community and in family members of those already living with diabetes. Diabetes education is a cornerstone of treatment but is often not culturally tailored and there is limited data on benefit of virtual delivery of sessions. Real Time Continuous glucose monitoring is a tool to improve diabetes but is not readily available to those living with type 2 diabetes not on multiple doses of insulin. Furthermore here is little to no data on RT-CGM use in different minority populations. Data is also lacking on if diabetes education for an individual affects the family unit. We hypothesize that culturally tailored Diabetes self-management education using and support (DSMES) using a team approach of health educators and Community health workers will improve glycemic indices. We further hypothesis that RT-CGM coupled to DSMES will enhances glycemic benefit and change nutrition and activity behaviors. This will be a randomized control trial of 100 Latinx participants who will all receive culturally tailored DSMES with or without cycle RT-CGM over 12 weeks. Primary outcome will be mean A1C improvement at 12 and 24 weeks based on attendance of sessions and RT-CGM use. Secondary outcomes will be satisfaction with education and CGM, changes in weight, blood pressure and self-reported nutrition and exercise changes. This study will be the first study to examine how DSMES with and without RT-CGM use improves health outcomes in the Latinx population and their families ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05394844
Study type	Interventional
Source	University of Washington
Contact	nicole ehrhardt
Phone	2065208500
Email	nehrhard@uw.edu
Status	Recruiting
Phase	N/A
Start date	November 11, 2022
Completion date	November 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05530356` - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Active, not recruiting	`NCT04954313` - Baseline Oral Health Study: UnCoVer the Connections to General Health	Phase 4
Not yet recruiting	`NCT06437782` - Exploration of Health Literacy in Diabetes in Reunion Island and France
Completed	`NCT01354925` - Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan	Phase 4
Completed	`NCT01206725` - Exercise Study on Cardiac Function in Patients With Diabetes Mellitus Type 2 and Diastolic Dysfunction	N/A
Completed	`NCT00997282` - A Study of OPC-262 in Patients With Type 2 Diabetes	Phase 2/Phase 3
Completed	`NCT00637546` - Gait and Balance of Diabetes Type 2 Patients	Phase 2/Phase 3
Completed	`NCT00464880` - Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy	Phase 1/Phase 2
Withdrawn	`NCT02057497` - An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms	N/A
Active, not recruiting	`NCT05014204` - Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes	N/A
Recruiting	`NCT03662217` - Personalized Nutrition for Diabetes Type 2	N/A
Completed	`NCT04276051` - Cryovagotomy Diabetes Trial	N/A
Completed	`NCT02569684` - Effects of Prebiotics on GLP-1 in Type 2 Diabetes	N/A
Active, not recruiting	`NCT01933529` - ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)	Phase 2
Terminated	`NCT01722474` - Assessment of Three Instruments for the Non-invasive Measurement of Arterial Stiffness.	N/A
Completed	`NCT00977262` - Postprandial Inflammation and Fatty Acids	N/A
Completed	`NCT00518427` - Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine	Phase 4
Recruiting	`NCT05378620` - Project Dulce for Filipino-Americans With Type 2 Diabetes	N/A
Recruiting	`NCT03834207` - A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy	N/A
Active, not recruiting	`NCT05228067` - Enhancing Brain Health by tDCS in Persons With Overweight and Obesity	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Diabetes Education With Real-time Continuous Glucose Monitoring — CUTDM

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms